Deutsche Bank Ag\ Bausch Health Companies Inc. Transaction History

Deutsche Bank Ag\

$248 Billion
Q4 2024

A detailed history of Deutsche Bank Ag\ transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 2,129,711 shares of BHC stock, worth $13.1 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,129,711

Previous 2,570,341 17.14%

Holding current value

$13.1 Million

Previous $20.9 Million 18.06%

% of portfolio

0.01%

Previous 0.01%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$7.34 - $9.78 $3.23 Million - $4.31 Million	-440,630 Reduced 17.14%	2,129,711 $17.2 Million
Q3 2024 Nov 13, 2024	SELL	$5.22 - $8.26 $1.81 Million - $2.87 Million	-347,000 Reduced 11.89%	2,570,341 $20.9 Million
Q2 2024 Aug 14, 2024	BUY	$6.1 - $10.41 $8.93 Million - $15.2 Million	1,463,487 Added 100.66%	2,917,341 $20.3 Million
Q1 2024 May 15, 2024	BUY	$7.77 - $10.61 $6.13 Million - $8.37 Million	788,805 Added 118.61%	1,453,854 $15.4 Million
Q4 2023 Feb 14, 2024	BUY	$6.53 - $8.23 $1.97 Million - $2.49 Million	302,199 Added 83.28%	665,049 $5.33 Million
Q3 2023 Nov 09, 2023	BUY	$7.69 - $9.71 $2.64 Million - $3.34 Million	343,624 Added 1787.29%	362,850 $2.98 Million
Q2 2023 Aug 14, 2023	BUY	$5.72 - $8.8 $3,231 - $4,972	565 Added 3.03%	19,226 $153,000
Q1 2023 May 15, 2023	BUY	$6.28 - $9.85 $41,448 - $65,010	6,600 Added 54.72%	18,661 $151,000
Q4 2022 Feb 13, 2023	SELL	$6.09 - $7.93 $1.65 Million - $2.15 Million	-271,627 Reduced 95.75%	12,061 $75,000
Q3 2022 Nov 14, 2022	SELL	$4.58 - $9.21 $119,963 - $241,237	-26,193 Reduced 8.45%	283,688 $1.95 Million
Q2 2022 Aug 11, 2022	SELL	$7.06 - $23.63 $10,978 - $36,744	-1,555 Reduced 0.5%	309,881 $2.59 Million
Q1 2022 May 13, 2022	BUY	$21.6 - $27.79 $123,444 - $158,819	5,715 Added 1.87%	311,436 $7.12 Million
Q4 2021 Feb 11, 2022	SELL	$23.0 - $29.01 $903,256 - $1.14 Million	-39,272 Reduced 11.38%	305,721 $8.44 Million
Q3 2021 Nov 04, 2021	SELL	$25.04 - $30.06 $267,777 - $321,461	-10,694 Reduced 3.01%	344,993 $9.61 Million
Q2 2021 Aug 11, 2021	BUY	$27.43 - $32.7 $2.18 Million - $2.59 Million	79,307 Added 28.69%	355,687 $10.4 Million
Q1 2021 May 13, 2021	BUY	$21.37 - $34.38 $137,622 - $221,407	6,440 Added 2.39%	276,380 $8.77 Million
Q4 2020 Feb 16, 2021	SELL	$15.31 - $21.12 $9.16 Million - $12.6 Million	-598,615 Reduced 68.92%	269,940 $5.62 Million
Q3 2020 Nov 12, 2020	SELL	$14.88 - $20.13 $128,979 - $174,486	-8,668 Reduced 0.99%	868,555 $13.5 Million
Q2 2020 Aug 13, 2020	SELL	$13.31 - $20.51 $2.47 Million - $3.81 Million	-185,815 Reduced 17.48%	877,223 $16 Million
Q1 2020 May 14, 2020	BUY	$12.98 - $30.25 $4.91 Million - $11.4 Million	378,030 Added 55.19%	1,063,038 $16.5 Million
Q4 2019 Feb 14, 2020	BUY	$18.89 - $31.89 $7.16 Million - $12.1 Million	378,779 Added 123.69%	685,008 $20.5 Million
Q3 2019 Nov 14, 2019	SELL	$20.88 - $25.66 $13 Million - $16 Million	-622,089 Reduced 67.01%	306,229 $6.69 Million
Q2 2019 Aug 14, 2019	BUY	$20.52 - $26.45 $2.41 Million - $3.1 Million	117,313 Added 14.47%	928,318 $23.4 Million
Q1 2019 May 15, 2019	SELL	$20.23 - $26.29 $1.89 Million - $2.46 Million	-93,433 Reduced 10.33%	811,005 $20 Million
Q4 2018 Feb 14, 2019	SELL	$17.64 - $28.32 $9.55 Million - $15.3 Million	-541,245 Reduced 37.44%	904,438 $16.7 Million
Q3 2018 Dec 21, 2021	BUY	$20.64 - $25.67 $1.82 Million - $2.27 Million	88,239 Added 6.5%	1,445,683 $37.1 Million
Q3 2018 Nov 14, 2018	BUY	$20.64 - $25.67 $28 Million - $34.8 Million	1,357,444 New	1,357,444 $34.8 Million

Others Institutions Holding BHC

# of Institutions

264

Shares Held

250M

Call Options Held

5.88M

Put Options Held

9.78M

View Full List

About Bausch Health Companies Inc.

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.23B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

More about BHC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account